Clinical trial
Real World Outcomes of Patients Treated With Vericiguat in German Routine Care
NCT06486844 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real World Outcomes of Patients Treated With Vericiguat in German Routine Care
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 5, 2024
- Completion date
- August 31, 2025
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure with reduced ejection fraction